Cleveland Biolabs Employee Directory
Biotechnology ResearchNew York, United States11-50 Employees
Cleveland BioLabs, Inc. is a clinical-stage biotechnology company focused on oncology and orphan drug development. Based in Buffalo, New York, it pursues research, development and commercialization of proprietary products intended to treat cancer, prevent and treat acute radiation syndrome, and counteract the toxic effects of radiation and chemotherapy for oncology patients. The company has a pipeline of nine product candidates being developed directly by Cleveland BioLabs and its majority-owned subsidiaries Incuron, LLC, and Panacela Labs, Inc. It was founded in 2003 and operates within the biotechnology research industry. In July 2021, Cleveland BioLabs completed a merger with Statera BioPharma, Inc.